← Back to Search

Pecto-intercostal fascial block for Autonomic Nerve Block

N/A
Recruiting
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
American Society of Anesthesiologists (ASA) physical status I-IV
Undergoing primary cardiac surgery requiring sternotomy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 48 hours after block procedure
Awards & highlights

Study Summary

This trial is studying the use of a nerve block with a local anesthetic to see if it improves pain control after surgery. Participants will be randomly assigned to receive either the nerve block or a saline solution

Who is the study for?
This trial is for individuals undergoing open heart surgery, who can have their medical history and medication use reviewed. They must be able to receive a nerve block in addition to standard pain control methods. There's no information on who cannot participate provided here.Check my eligibility
What is being tested?
The study tests if adding a bilateral nerve block with ropivacaine (a local anesthetic) improves pain management after open heart surgery compared to using saline solution, alongside regular pain relief measures.See study design
What are the potential side effects?
Possible side effects of the Pecto-Intercostal Fascial Block may include discomfort at the injection site, potential numbness or weakness in the chest wall, and rare complications related to nerve blocks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My health is classified between ASA I and IV.
Select...
I am scheduled for heart surgery that involves opening my chest.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours after block procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours after block procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence nausea and/or vomiting after surgery
NRS pain score at 48 hours
OPIOID consumption at 24 hours
+4 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Pecto-intercostal fascial blockActive Control1 Intervention
Pecto-intercostal Fascial Block with 20 ml of 0.35% ropivacaine injected to each side under ultrasound visualization.
Group II: PlaceboPlacebo Group1 Intervention
Pecto-intercostal Fascial Block with 20ml of normal saline injected to each side under ultrasound visualization.

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
830 Previous Clinical Trials
505,536 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research study currently accepting new participants?

"Indeed, as per the information available on clinicaltrials.gov, this research study is actively seeking eligible participants. The trial was originally posted on October 16th, 2023 and was last updated on January 22nd, 2024. There is a requirement to enroll a total of 84 individuals across one designated site."

Answered by AI

What is the current number of individuals actively engaged in this clinical investigation?

"Indeed, the information available on clinicaltrials.gov indicates that this trial is actively seeking eligible candidates. The initial posting date was recorded as October 16, 2023, and the most recent update occurred on January 22, 2024. In order to complete the study successfully, a total of 84 participants are being sought from a single designated site."

Answered by AI
~56 spots leftby Dec 2026